Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper

Objective—The involvement of transition metals in atherosclerosis is controversial. Some epidemiological studies have reported a relationship between iron (Fe) and cardiovascular disease, whereas others have not. Experimental studies have reported elevated levels of iron and copper (Cu) in diseased human arteries but have often used methods that release metal ions from proteins. Methods and Results—In this study, we have used the minimally invasive technique of electron paramagnetic resonance (EPR) spectroscopy and inductively coupled plasma mass spectroscopy (ICPMS) to quantify iron and copper in ex vivo healthy human arteries and carotid lesions. The EPR spectra detected are characteristic of nonheme Fe(III) complexes. Statistically elevated levels of iron were detected in the intima of lesions compared with healthy controls (0.370 versus 0.022 nmol/mg tissue for EPR, 0.525 versus 0.168 nmol/mg tissue by ICPMS, P <0.05 in each cases). Elevated levels of copper were also detected (7.51 versus 2.01 pmol/mg tissue, lesion versus healthy control, respectively, P <0.05). Iron levels did not correlate with the gender or age of the donor, or tissue protein or calcium levels, but cholesterol levels correlated positively with iron accumulation, as measured by EPR. Conclusions—These data support the hypothesis that iron accumulates in human lesions and may contribute to disease progression.

[1]  L. Jarczyk,et al.  Elemental composition of the human atherosclerotic artery wall , 2004, Histochemistry.

[2]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[3]  B. Halliwell,et al.  Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. , 2003, Free radical biology & medicine.

[4]  M. Davies,et al.  Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. , 2003, The Biochemical journal.

[5]  R. Dean,et al.  Comparative time-courses of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein. , 2002, Archives of biochemistry and biophysics.

[6]  G. Ferns,et al.  Biphasic modulation of atherosclerosis induced by graded dietary copper supplementation in the cholesterol‐fed rabbit , 2001, International journal of experimental pathology.

[7]  M. Suematsu,et al.  Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[8]  B. Halliwell,et al.  Nuclear microscopy of atherosclerotic tissue: A review , 2001 .

[9]  J. Valentine,et al.  Yeast Lacking Superoxide Dismutase(s) Show Elevated Levels of “Free Iron” as Measured by Whole Cell Electron Paramagnetic Resonance* , 2000, The Journal of Biological Chemistry.

[10]  R. Dean,et al.  Stable markers of oxidant damage to proteins and their application in the study of human disease. , 1999, Free radical biology & medicine.

[11]  J. Mattana,et al.  Oxidation of extracellular matrix modulates susceptibility to degradation by the mesangial matrix metalloproteinase-2. , 1999, Free radical biology & medicine.

[12]  J. Marx,et al.  Iron, atherosclerosis, and ischemic heart disease. , 1999, Archives of internal medicine.

[13]  L. Horwitz,et al.  Iron-mediated cardiovascular injury , 1999, Vascular medicine.

[14]  J. Danesh,et al.  Coronary heart disease and iron status: meta-analyses of prospective studies. , 1999, Circulation.

[15]  G. Mann,et al.  Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? , 1999, Cardiovascular research.

[16]  J. Heinecke Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. , 1998, Atherosclerosis.

[17]  R. Dean,et al.  Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. , 1998, The Biochemical journal.

[18]  Xi-Ming Yuan,et al.  Iron and LDL‐oxidation in atherogenesis. , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  Tzong-Shyuan Lee,et al.  Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.

[20]  P. Libby,et al.  Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. , 1998, The American journal of medicine.

[21]  S. L. Hazen,et al.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. , 1997, The Journal of clinical investigation.

[22]  M. Davies,et al.  Oxidative damage to collagen and related substrates by metal ion/hydrogen peroxide systems: random attack or site-specific damage? , 1997, Biochimica et biophysica acta.

[23]  S. L. Hazen,et al.  Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima* , 1997, The Journal of Biological Chemistry.

[24]  J. Imlay,et al.  Superoxide accelerates DNA damage by elevating free-iron levels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Wei Li,et al.  Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. , 1996, Atherosclerosis.

[26]  Y. L. Chen,et al.  Increased ferritin gene expression in atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[27]  R. Stocker,et al.  Presence of hypochlorite-modified proteins in human atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[28]  J. Pallon,et al.  Nuclear microprobe applied to the study of coronary artery walls--a distinct look at atherogenesis. , 1996, Cellular and molecular biology.

[29]  P. Thong,et al.  Elemental changes in atherosclerotic lesions using nuclear microscopy. , 1996, Cellular and molecular biology.

[30]  D. Leake,et al.  Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages , 1995, FEBS letters.

[31]  R. Dean,et al.  Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution. , 1995, Archives of biochemistry and biophysics.

[32]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[33]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.

[34]  J. Gutteridge,et al.  Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material , 1995, FEBS letters.

[35]  V. A. Folcik,et al.  Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[36]  B. Halliwell,et al.  Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. , 1995, Free radical research.

[37]  J. Pallon,et al.  Applications in medicine using the new Lund microprobe , 1993 .

[38]  M. Jackson,et al.  Electron paramagnetic resonance spectroscopy of stable free radicals in the liver compared with ultrastructural and functional damage in a rat model of alcohol- and iron-overload. , 1993, Clinical science.

[39]  K. Uchida,et al.  Oxidative fragmentation of collagen and prolyl peptide by Cu(II)/H2O2. Conversion of proline residue to 2-pyrrolidone. , 1992, The Journal of biological chemistry.

[40]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[41]  M. Dubick,et al.  Effects of Hypertension on Aortic Antioxidant Status in Human Abdominal Aneurysmal and Occlusive Disease , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[43]  J. Kanner,et al.  Iron release from metmyoglobin, methaemoglobin and cytochrome c by a system generating hydrogen peroxide. , 1988, Free radical research communications.

[44]  S. McGowan,et al.  Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. , 2015, The American review of respiratory disease.

[45]  C. Winterbourn,et al.  The effect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen. , 1986, Biochimica et Biophysica Acta.

[46]  S. Weiss,et al.  Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. , 1986, Journal of immunology.

[47]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[48]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[49]  Martyn C. R. Symons,et al.  Chemical and Biochemical Aspects of Electron Spin Resonance Spectroscopy , 1978 .

[50]  N. Dodd Biological Applications of Electron Spin Resonance , 1973 .

[51]  J. Bolton,et al.  Biological applications of electron spin resonance , 1972 .